Effect of NXY-059 on secondary mitochondrial dysfunction after transient focal ischemia; comparison with cyclosporin A

Brain Research
Tetsuyuki YoshimotoB K Siesjö

Abstract

The free radical trapping agents NXY-059 and alpha-phenyl-N-tert.-butylnitrone (PBN) markedly reduce infarct volume, even when given 1 or 3 h after the start of recirculation, following 2 h of middle cerebral artery (MCA) occlusion in rats. Their anti-ischemic effects are shared by the two immunosuppressants cyclosporin A (CsA) and FK506. Interestingly, CsA causes an additional reduction in infarct volume when given after only 5 min of recirculation, possibly reflecting blockade of a mitochondrial permeability transition (MPT) pore. PBN, CsA and FK506 are known to ameliorate the secondary dysfunction of mitochondrial function, as assessed in vitro, which occurs during the first 4-6 h of recirculation. The present experiments were undertaken to assess whether NXY-059 reduces tissue damage by acting directly on mitochondrial membranes, and provided that this is the case, if blockade of an MPT is involved. The results were compared to those of CsA, which thus served as a reference compound. NXY-059 was given i.v. after 5 min and 1 h, and CsA after 5 min of recirculation. Both NXY-059 and CsA reduced infarct volumes to about 30% of control, prevented the secondary decline in mitochondrial respiratory function during recirculation, ...Continue Reading

Citations

Oct 7, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Alessandra PaganoConstance Barazzone Argiroffo
Dec 14, 2004·International Journal of Clinical Practice·C X Wang, A Shuaib
Jan 25, 2008·Der Nervenarzt·A Rogalewski, W-R Schäbitz
Mar 2, 2006·The Annals of Pharmacotherapy·Jeffrey J Fong, Denise H Rhoney
Dec 17, 2008·Stroke; a Journal of Cerebral Circulation·Maria PhilipSean I Savitz
May 9, 2009·British Journal of Pharmacology·P M W BathUNKNOWN NXY-059 Efficacy Meta-analysis in Individual Animals with Stroke Investigators
Oct 8, 2003·CNS Drug Reviews·Paul A Lapchak, Dalia M Araujo
Apr 23, 2005·Glia·Gerald A Dienel, Leif Hertz
Mar 1, 2008·Stroke; a Journal of Cerebral Circulation·Sean I Savitz, Wolf-Rüdiger Schäbitz
Nov 26, 2019·Biochemistry. Biokhimii︠a︡·A Galkin
Sep 4, 2003·Annals of Neurology·Myron D GinsbergLudmila Belayev
Jul 19, 2008·Stroke; a Journal of Cerebral Circulation·Malcolm R MacleodGeoffrey A Donnan
Sep 9, 2019·Molecular and Cellular Neurosciences·Vadim Ten, Alexander Galkin
May 18, 2004·Neurochemistry International·Yi-Bing Ouyang, Rona G Giffard
Jul 22, 2008·Neuropharmacology·Leif Hertz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.